Omeros | OMER - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Adma Biologics USD 57.13M 4.47M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -162.1M 164.84M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
MacroGenics USD -36.77M 21.84M 2026-03
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Xoma USD 15.98M 24.58M 2024-06